About the Authors

Laura Ciarloni

Affiliations Diagnoplex SA, Epalinges, Switzerland, Novigenix SA, Epalinges, Switzerland

Sahar Hosseinian

Affiliations Diagnoplex SA, Epalinges, Switzerland, Novigenix SA, Epalinges, Switzerland

Sylvain Monnier-Benoit

Affiliations Diagnoplex SA, Epalinges, Switzerland, Novigenix SA, Epalinges, Switzerland

Natsuko Imaizumi

Current address: Medtronic, Tolochenaz, Switzerland

Affiliations Diagnoplex SA, Epalinges, Switzerland, National Center for Competence in Research (NCCR), Molecular Oncology, Swiss Institute for Experimental Cancer Research (ISREC)-Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Gian Dorta

Affiliation Department of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland

Curzio Ruegg

curzio.ruegg@unifr.ch

Affiliations Novigenix SA, Epalinges, Switzerland, National Center for Competence in Research (NCCR), Molecular Oncology, Swiss Institute for Experimental Cancer Research (ISREC)-Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, Department of Medicine, Faculty of Science, University of Fribourg, Fribourg, Switzerland

On behalf of the DGNP-COL-0310 Study Group

Membership of the DGNP-COL-0310 Study Group is provided in the Acknowledgments.

Competing Interests

LC SH SMB NI were employees of Diagnoplex SA at the time of the study. Also, they own stock options in Diagnoplex SA. CR is a co-founder, advisory board member and owns stocks and shares of Diagnoplex SA. GD has served as speaker, consultant and advisory board member for Diagnoplex SA, and has received research funding from Diagnoplex SA. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: LC SH SMB NI GD CR. Performed the experiments: LC SMB SH. Analyzed the data: LC SMB SH. Contributed reagents/materials/analysis tools: SH GD. Wrote the paper: LC SH SMB CR. Writing clinical protocol: NI GD.